1-Docosanol
CASRN#
661-19-8, 30303-65-2
INCI Name
BEHENYL ALCOHOL
Alternate Names
Docosan-1-ol; Behenyl alcohol; Docosanol; Behenic alcohol; Docosyl alcohol; nDocosanol; Brassica alcohol
Common Trade Names
Abreva; Tadenan; Lidavol; Lanette 22
Molecular Weight
327 g/mol
Functional Uses
thickener, emulsifier, emollient, opacifier
Common Impurities
-
Is this a VOC?
Yes
Is this an exempt VOC?
No
Vapor Pressure
6.13E-8 mm Hg
Octanol-water partition coefficient (log Kow)
9.68
Solubility at 25 C
0.000075 mg/l
Boiling Point
180 °C
Particle size range as aerodynamic diameter
- - - μm
Hazard Summary
C2C Chemical Rating
c/b
GHS Health
H320
GHS Enviro
None
Assessed by
U.S. EPA Low Priority Chemical report.
Assessment Date
Jul 10, 2020
Assessment Expires
Jul 10, 2025
Verification Status
verified
Executive Summary
1-Docosanol is a long-chain, saturated fatty alcohol that is a water-insoluble, waxy solid. Fatty alcohols are usually high-molecular-weight, straight-chain primary alcohols derived from natural fats and oils. Saturated fatty alcohols have no carbon-carbon double bonds, and have the formula – CH3(CH2)nOH – with variations in “n.” Specifically, 1-docosanol is a saturated aliphatic alcohol with a 22-carbon chain, known as docosane, with a hydroxy group (-OH) at the terminal carbon and the formula CH3(CH2)21OH. This chemical has uses in consumer and industrial products, as well as in pharmaceutical products. 1-Docosanol functions as a thickener, emulsifier, emollient, and binder in a variety of applications and product sectors. NOTE: The data provided in this assessment came primarily from the US EPA final designation report, Supporting Information for Low-Priority Substance 1-Docosanol (Brassica Alcohol) (https://www.regulations.gov/document?D=EPA-HQ-OPPT-2019-0114-0009). According to US EPA, “low-priority substance designations give the public notice of chemical substances for which the hazard and/or exposure potential is anticipated to be low or nonexistent and provides some insight into which chemical substances are likely not to need additional evaluation and risk management under TSCA.”
Hazard Tables

How to read the GHS Hazard Summary Table

 
Carcinogenicity
Mutagenicity
Reproductive Toxicity
Developmental Toxicity
Acute Toxicity
STOT-Single
STOT-Repeated
STOT- Neurotoxicity-Single
STOT- Neurotoxicity-Repeated
Skin Sensitizer
Respiratory Sensitizer
Skin Corrosion/Irritation
Serious Eye Damage/Eye Irritation
Acute Aquatic Toxicity
Chronic Aquatic Toxicity
Ozone Depletion
Oral
Dermal
Inhalation
NC
Rationale
Available data is insufficient for GHS classification: 1-docosanol's transformation profile, lack of structural alerts, noncarcinogenic predictions, and absence of genotoxicity in experimental studies provide sufficient information to indicate this chemical is unlikely to be carcinogenic.
NC
Rationale
Available data is insufficient for GHS classification: 1-docosanol's transformation profile, lack of structural alerts, noncarcinogenic predictions, and absence of genotoxicity in experimental studies provide sufficient information to indicate this chemical is unlikely to be carcinogenic.
NC
Rationale
Available data is insufficient for GHS classification: 1-docosanol's transformation profile, lack of structural alerts, noncarcinogenic predictions, and absence of genotoxicity in experimental studies provide sufficient information to indicate this chemical is unlikely to be carcinogenic.
NC
Rationale
Multiple studies provide sufficient evidence to indicate a low concern for genotoxicity.
NC
Rationale
No reproductive effects were observed in a reproductive study which provides sufficient evidence to indicate low concern for reproductive toxicity.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Multiple studies provide sufficient evidence to indicate a low concern for developmental toxicity.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Multiple studies provide sufficient evidence to indicate low concern for acute oral toxicity.
NC
Rationale
Studies from analogs provide sufficient evidence to indicate a low concern for acute dermal toxicity. Lower confidence due to analogs.
NC
Rationale
Studies from analogs provide sufficient information to indicate a low concern for acute inhalation toxicity since no adverse effects were seen at saturated air concentration.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Multiple studies provide sufficient evidence to indicate low concern for repeat dose oral toxicity.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Based on the neurological evidence from the repeated dose studies, and supporting evidence indicating low concern for other endpoints, such as acute, reproductive, and developmental toxicity, provides sufficient information to indicate low concern for neurotoxicity.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Based on the neurological evidence from the repeated dose studies, and supporting evidence indicating low concern for other endpoints, such as acute, reproductive, and developmental toxicity, provides sufficient information to indicate low concern for neurotoxicity.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
No structural alerts identified for skin sensitization. Lower confidence because a lack of structural alerts is insufficient for establishing a GHS classification.
NC
Rationale
No structural alerts identified for respiratory sensitization. Lower confidence because a lack of structural alerts is insufficient for establishing a GHS classification.
NC
Rationale
An OECD Guideline 404 study provides sufficient evidence to indicate a low concern for skin irritation.
Cat 2B
Rationale
Multiple studies provides sufficient evidence to indicate moderate concern for eye irritation.
NC
Rationale
Multiple studies provide sufficient evidence to indicate low concer for acute aquatic exposure based on no effects at saturation.
NC
Rationale
Modelling and studies on aquatic invertebrates provide sufficient evidence to indicate low concer for chronic aquatic exposure based on no effects at saturation.
NC
Rationale
Chemical is not on Montreal Protocol or IPCC List.
Other
  • Explosives: Not classified
  • Flammable Gases: Not classified
  • Aerosols: Not classified
  • Oxidizing Gases: Not classified
  • Flammable Liquids: Not classified
  • Flammable Solids: Not classified
  • Self-reactive substances and mixtures: Not classified
  • Pyrophoric Liquids: Not classified
  • Pyrophoric Solids: Not classified
  • Self-heating Substances and Mixtures: Not classified
  • Substances and Mixtures which in contact with water, emit flammable gases: Not classified
  • Oxidizing Liquids: Not classified
  • Oxidizing Solids: Not classified
  • Organic Peroxides: Not classified
  • Corrosive to Metals: Not classified
  • Desensitized Explosives: Not classified
  • Lactation Toxicity: Classification not possible (Data gap or insufficient data)
  • Aspiration: Classification not possible (Data gap or insufficient data)

How to read the C2CC Hazard Summary Table

Human Health
Environmental
Other
 
Carcinogenicity
Mutagenicity
Reproductive & Developmental Toxicity
Endocrine Activity / Disruption
Oral Toxicity
Dermal Toxicity
Inhalation Toxicity
Neurotoxicity
Skin, Eye, and Respiratory Corrosion/Irritation
Sensitization of Skin and Airways
Fish Toxicity
Daphnia Toxicity
Algae Toxicity
Terrestrial Toxicity
Persistence
Bioaccumulation
Climatic Relevance
Other (Human Health)
Organohalogens
Toxic Metals
Other (Environmental Health)
Oral
Dermal
Inhalation
-
-
-
G
G
-
-
-
Rationale
Data not available.
G
G
G
G
-
-
Y
G
G
G
G
-
G
Rationale
Multiple studies provide sufficient information to indicate low concern for persistence. Lower confidence due to analogs.
G
Rationale
Studies on analogs provide sufficient information to indicate low concern for bioaccumulation.
Y
G
Rationale
No additional data available.
G
G
G
Rationale
No data available.